Literature DB >> 2549053

In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase II. Cell cycle analysis.

M M Heck1, W N Hittelman, W C Earnshaw.   

Abstract

We have examined the level of incorporation of 32P into DNA topoisomerase II in vivo in chicken lymphoblastoid cells that were fractionated into the various cell cycle phases by centrifugal elutriation. We find that topoisomerase II is phosphorylated in vivo, with the level of incorporation being approximately 3.5-fold higher in the G2 + M fraction than earlier in the cell cycle. Our antibody studies have revealed that topoisomerase II antigen exists as a number of discrete polypeptide species in these cells. Of these, the 170-kDa intact polypeptide is phosphorylated approximately 4.5-fold more than several antigenic fragments that actually comprise the bulk of the topoisomerase II antigen in these cells at mitosis. Phosphorylation of the 170-kDa form of the enzyme may be involved in activation of the enzyme for its role in the disjunction of sister chromatids at anaphase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Proteomic analysis of human metaphase chromosomes reveals topoisomerase II alpha as an Aurora B substrate.

Authors:  Ciaran Morrison; Alexander J Henzing; Ole Nørregaard Jensen; Neil Osheroff; Helen Dodson; Stefanie E Kandels-Lewis; Richard R Adams; William C Earnshaw
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 2.  Topoisomerase II: its functions and phosphorylation.

Authors:  S M Gasser; R Walter; Q Dang; M E Cardenas
Journal:  Antonie Van Leeuwenhoek       Date:  1992-08       Impact factor: 2.271

3.  Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Authors:  Adrian G Grozav; Belinda B Willard; Toshiyuki Kozuki; Kenichi Chikamori; Marius A Micluta; Andrei-Jose Petrescu; Michael Kinter; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Proteomics       Date:  2011-01-31       Impact factor: 3.984

4.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2.

Authors:  S Taagepera; P N Rao; F H Drake; G J Gorbsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase.

Authors:  P Belenguer; M Caizergues-Ferrer; J C Labbé; M Dorée; F Amalric
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle.

Authors:  Carmen K M Mak; Victor K L Hung; Joseph T Y Wong
Journal:  Chromosoma       Date:  2005-11-15       Impact factor: 4.316

8.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Authors:  P R Caron; P Watt; J C Wang
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.

Authors:  M Aoyama; D R Grabowski; G R Dubyak; A I Constantinou; L A Rybicki; R M Bukowski; M K Ganapathi; I D Hickson; R Ganapathi
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.